Objective Assessment of Outcomes Following Immediate Lymphatic Reconstruction / LYMPHA
Recruiting now
Conditions studied: Lymphatic Reconstruction
In brief
Immediate lymphatic reconstruction (ILR) is a novel surgical approach performed at the time of initial lymph node dissection with the goal of preventing lymphedema. It involves the identification of lymphatic channels that are transected after lymph node dissection and microsurgical anastomosis of one or more lymphatic channel with a local recipient vein to re-direct upper extremity lymphatic drainage. Although ILR carries significant promise in prevention of lymphedema, there is a lack of high-level evidence supporting its efficacy because it is a novel surgical technique that is only offered at a few centers and not routinely covered by insurance carriers yet. The University of Chicago Comprehensive Cancer Center (UCCCC) is one of the busiest microsurgery centers performing this procedure, and, as a Lymphedema Center of Excellence, is in a unique position to investigate the efficacy of ILR in preventing lymphedema. In addition, the University has access to a world class microbiome research facility and colleagues. There is no information on the skin microbiome of the axilla in patients undergoing treatment for breast cancer or those at risk for developing lymphedema. Further exploratory studies such as this in a diverse patient population may lead to practice changing research in our approach to lymphedema management and prevention. The purpose of this study is to determine the role of immediate lymphatic reconstruction and obtain objective data to correlate the existing, self-reported rates of lymphedema at the University of Chicago.
Key facts
- Study ID
- NCT06650592
- Run by
- University of Chicago
- People needed
- 90
- Starts
- 2024-11-26
- Expected to finish
- 2029-10-01
- Last updated by the study team
- 2026-02-02
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- All patients who were candidates for Immediate Lymphatic Reconstruction (ILR)
You may not qualify if…
- None
Where it is running
- The University o Chicago — Chicago, Illinois, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.